Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-30 4:35 pm Purchase |
2025-04-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Venrock Healthcare Capital Partners III, L.P. | 6,596,885 7.700% |
3,414,358 (+107.28%) |
Filing |
| 2025-05-15 5:47 pm Sale |
2025-03-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Venrock Healthcare Capital Partners III, L.P. | 3,182,527 4.500% |
-1,245,858 (-28.13%) |
Filing |
| 2024-02-01 4:15 pm Purchase |
2024-01-22 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Venrock Healthcare Capital Partners III, L.P. | 4,428,385 6.600% |
4,428,385 (New Position) |
Filing |